Quetiapine Fumarate Tablets IP 25Mg – QYNERA 25 Tablets

QYNERA 25
Composition:- Quetiapine Fumarate 25mg

QYNERA 25 Tablets, a psychiatry segment brand of Wonne International, contains Quetiapine Fumarate Tablets IP 25 mg, an atypical antipsychotic that modulates serotonin and dopamine receptors in the brain. It is widely used for the management of psychiatric disorders by stabilizing mood, reducing hallucinations, and improving overall mental well-being.

Marketed by: Wonne International Pvt. Ltd.

Key Points of Quetiapine Fumarate Tablets IP 25Mg – QYNERA 25 Tablets

• Effective Symptom Control: It is indicated for the treatment of psychological conditions such as schizophrenia and bipolar disorder, including hallucinations, mood swings, and agitation.
• Mood Stabilization: Along with psychological action, it also balances neurotransmitter activity to support emotional stability in both manic and depressive episodes.
• Anxiolytic & Calming Effect: Reduces anxiety, restlessness, and irritability, improving patient comfort.
• Suitable for Long-term Therapy: Can be used for maintenance treatment under proper medical supervision.

Can be Prescribed by:

• Psychiatrist
• Neurologist
• General Physician

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.